DUBLIN--(BUSINESS WIRE)--The "Global Hematology Analyzers and Reagents Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The hematology analyzers and reagents market will register a CAGR of nearly 6% by 2023.
The growing demand for blood and blood components will be one of the key factors expected to trigger the hematology analyzers and reagents market growth in the forthcoming years. Blood component therapy allows patients for benefitting from one pint of whole blood.
Blood and its components are required when the body fails in producing enough blood components for meeting the body's requirements. As a result, the rising demand for blood and blood components for treating medical conditions is further boosting the demand for hematology analyzers for measuring blood constituents.
The rising number of organ transplant procedures
One of the growth drivers of the global hematology analyzers and reagents market is the rising number of organ transplant procedures. During transplantation, red blood cells transfusion is required to support the functioning of the organs which necessitates the need for hematology analyzers.
Lack of adoption of automated hematology analyzer solutions by smaller laboratories
One of the challenges in the growth of global hematology analyzers and reagents market is the lack of adoption of automated hematology analyzer solutions by smaller laboratories. The high cost of the initial set up and instrumentation and the subsequent cost of maintenance are likely to affect the demand for hematology analyzers.
Competitive Landscape
The market appears to be moderately concentrated and with the presence of a few market players. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.
Key Players
- Abbott
- Bio-Rad Laboratories Inc.
- Danaher
- F. Hoffmann-La Roche Ltd.
- Sysmex Corporation
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY END-USER
- Comparison by end-user
- Hospitals and diagnostic centers - Market size and forecast 2018-2023
- Blood bank centers - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- RoW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- Bio-Rad Laboratories Inc.
- Danaher
- F. Hoffmann-La Roche Ltd.
- Sysmex Corporation
For more information about this report visit https://www.researchandmarkets.com/r/3sqbbt